Left ventricular outflow tract (LVOT) obstruction with systolic anterior motion (SAM) of mitral valve is commonly encountered in patients with hypertrophic cardiomyopathy \[[@B1]\], but it can also be observed in other conditions \[[@B2]-[@B7]\]. Dynamic interaction between anatomy and mechanics of the heart may cause LVOT obstruction with SAM which can potentially deteriorate the hemodynamics of the circulatory system.

We present a case of LVOT obstruction with SAM in a patient who had a large amount of pericardial effusion which resulted from ascending aortic dissection. Pericardial effusion may restrict left ventricular volume and therefore result in hyperdynamic left ventricle which may predispose to LVOT obstruction with SAM. Hypotensive agents used for the control of blood pressure in aortic dissection can potentially reduce preload and vascular resistance of the circulatory system, which may aggravate LVOT obstruction with SAM. The use of Intraoperative transesophageal echocardiography is important to recognize this pathophysiology in clinically unstable patients, and aids to establish an appropriate therapeutic strategy.

Case Report
===========

A 72-year-old woman (145 cm, 47 kg) who was diagnosed with ascending aortic dissection presented for ascending aorta and hemiarch replacement surgery. She visited the emergency department with chest discomfort, nausea, and vomiting which started the day before. Her past medical history included common bile duct stone and hypertension that was controlled with an angiotensin receptor blocker. On arrival, her vital signs were stable with a blood pressure of 147/100 mmHg and heart rate of 86 beats per minute (bpm). Physical examination revealed abdominal tenderness on her epigastric area. Her chest X-ray showed bilateral pleural effusion, while her electrocardiogram (ECG) was normal . A chest computed tomography (CT) revealed Stanford type A aortic dissection that started from the aortic root through the proximal descending aorta that resulted in a large amount of pericardial effusion. Immediate emergent operation was planned, and transthoracic echocardiography (TTE) could not be performed.

When she arrived in the operating room, electrocardiography, pulse oxymetry and invasive blood pressure monitoring was conducted. Her blood pressure was managed with continuous infusion of nicardipine 2 µg/kg/min, esmolol 100 µg/kg/min, nitroglycerin 2 µg/kg/min, and nitroprusside 0.5 µg/kg/min. The initial vital signs checked in the operating room were stable with blood pressure of 100/56 mmHg and heart rate of 86 bpm. Induction of anesthesia was performed with 7 mg of midazolam, 50 µg of sufentanil, and 10 mg of vecuronium. After the injection of the induction agents, her blood pressure decreased to 76/46 mmHg, and the maximum heart rate noted at the time was 100 bpm. The infusion of the hypotensive agents (nicardipine, esmolol, nitroglycerin and nitroprusside) was discontinued, and subsequently 10 mg of ephedrine, 30 µg of phenylephrine and rapid volume infusion using lactate Ringer\'s solution were administered. In response to persistent hypotension, 10 mg of ephedrine was administered again, but hypotension was exacerbated resulting in a blood pressure of 66/42 mmHg. After endotracheal intubation, transesophageal echocardiography (TEE) was performed to evaluate cardiac function and to guide the hemodynamic treatment. TEE showed a large amount of pericardial effusion ([Fig. 1](#F1){ref-type="fig"}), septal hypertrophy, severe eccentric mitral regurgitation and systolic anterior motion (SAM) of mitral valve combined with dynamic left ventricular outflow tract (LVOT) obstruction ([Fig. 2](#F2){ref-type="fig"}). To improve LVOT obstruction with SAM, 50 mg of esmolol and several 100 µg boluses of phenylephrine , and more rapid volume resuscitation (300 ml of lactate Ringer\'s solution and 300 ml of hydroxyethyl starch solution) were administered. Afterwards, the patient\'s blood pressure became stable at 102/56 mmHg and heart rate of 88 bpm. LVOT obstruction with SAM improved, and mitral regurgitation decreased to a mild level. A triple lumen catheter with introducer (Advanced Venous Access®) was placed in the right internal jugular vein and a pulmonary artery catheter was inserted to monitor the central venous and pulmonary artery pressure. Anesthesia was maintained with propofol (1.5-2.5 µg/ml), and remifentanil (8-20 ng/ml) by target controlled infusion system under bispectral index monitoring. Vecuronium was infused continuously (1 µg/kg/min) for muscle relaxation.

Following sternotomy and opening of pericardium, about 200 ml of bloody pericardial effusion was drained for evacuation. After the drainage, residual SAM and mitral regurgitation completely disappeared on TEE. An ascending aorta and hemiarch replacement was conducted under cardiopulmonary bypass (CPB). While attempting to wean from CPB, SAM with LVOT obstruction reappeared. Esmolol was administered with bolus (50 mg) and continuous infusion (50 µg/kg/min). Afterwards, SAM with LVOT obstruction improved, and patient was weaned from CPB successfully. Postoperative TTE was performed one week after surgery and revealed no evidence of SAM. She was discharged from the hospital 11 days following the operation without major complications.

Discussion
==========

Hypertrophic cardiomyopathy is the most common cause of dynamic left ventricle outflow tract (LVOT) obstruction with systolic anterior motion (SAM) of mitral valve \[[@B1]\]. However, LVOT obstruction also occurs in other conditions without cardiac history, such as mitral valve repair \[[@B2]\], myocardial infarction \[[@B3]\], dobutamine stress test \[[@B4]\], liver transplantation \[[@B5],[@B6]\] and catecholamine infusion \[[@B7]\]. LVOT obstruction with SAM is induced by structural abnormalities such as small hyperdynamic left ventricular cavity, narrow LVOT, sigmoid septum, and displaced mobile elongated mitral leaflets \[[@B8]\]. This mechanism may be dynamic depending on the hemodynamics and anatomic conditions.

In this case, LVOT obstruction with SAM was found during induction of anesthesia and disappeared after the drainage of pericardial effusion. Although it is uncertain exactly when LVOT obstruction with SAM developed, this patient showed hemodynamic deterioration after the administration of anesthetic agents. Several factors might have been involved which led to the development of this condition. First, this patient had septal hypertrophy and small ventricular volume restricted by pericardial effusion which might have predisposed to LVOT obstruction. Second, preoperative use of hypotensive agents would have decreased preload and systemic vascular resistance (SVR), and anesthetic agents might have caused further reduction of SVR. Third, hyperdynamic activity of the left ventricle to compensate pericardial effusion might have aggravated LVOT obstruction with SAM, as evidenced by disappearance of SAM after the drainage of bloody pericardial effusion. This decrease of preload, combined with the sudden reduction of SVR, may lead LVOT obstruction with SAM in patients with predisposing factors.

Patients with aortic dissection are usually managed with hypotensive agents to control hypertension which may exacerbate the dissection. Sometimes pericardial effusion or even cardiac tamponade could be accompanied with aortic dissection. These pre-existing conditions may elevate the risk of LVOT obstruction due to decreased SVR and hyperdynamic cardiac status. In cases of relative hypovolemia, hyperdynamic cardiac state is further worsened and LVOT obstruction may occur.

Treatment of LVOT obstruction with SAM consists of increasing preload and decreasing the hyperdynamic state of the heart. Preload can be increased by aggressive intravascular volume infusion to increase the left ventricular end diastolic dimension. Increasing of SVR using vasopressors can be helpful by decreasing the Venturi effect on the LVOT. Beta adrenergic receptor blockers have proven effective in the treatment of hypertrophic cardiomyopathy, and their efficacy is also valid in the management of LVOT obstruction with SAM \[[@B9]\]. In the current case, massive volume infusion was performed and intravenous esmolol and phenylephrine was administered. Positive inotropes may aggravate LVOT obstruction with SAM and induce paradoxic decrease in blood pressure. Inotropic support and volume resuscitation are preferentially considered in cases of hypotension during anesthesia induction; however, inotropic agents are known to induce the hyperdynamic state and worsen mitral regurgitation with SAM in patients with predisposing LVOT obstruction. On the other hand, the treatment strategy for LVOT obstruction with SAM may aggravate hemodynamic deterioration if hypotension was not caused by SAM. Therefore, a differential diagnosis using echocardiography is essential for refractory hypotension.

LVOT obstruction with SAM is suspected with hemodynamic deterioration after catecholamine infusion, and new development of systolic murmur. However, definitive diagnosis requires performing echocardiography. In this case, TEE played an essential role in the diagnosis and management of LVOT obstruction with SAM. Findings on TEE revealed that administration of phenylephrine and esmolol and infusion of a large amount of fluid led to hemodynamic improvement. Although LVOT obstruction with SAM is diagnosed with echocardiography, CT scan or magnetic resonance imaging (MRI) is preferred in cases of aortic dissection because of their ability to evaluate the anatomical structures and the extent of the disease. However, CT scan and MRI are not suitable in evaluating functional and anatomic status of the aortic valve and they do not evaluate the dynamicity of left ventricular dysfunction \[[@B10]\]. In the current case, the dynamic effects of pericardial effusion and septal hypertrophy which may predispose to LVOT obstruction were discovered in the operating room because preoperative echocardiography was not performed.

In conclusion, LVOTO with SAM should be considered as a cause of refractory hypotension in patients with large amounts of pericardial effusion. Echocardiography is essential for the diagnosis and exact treatment. In cases of refractory hypotension which do not respond to conventional inotropic support, TEE should be performed to evaluate dynamic cardiac function.
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![(A) Color Doppler image showing mitral regurgitation and flow acceleration in the left ventricular outflow tract. (B) Without color Doppler, the transesophageal echocardiography showing septal hypertrophy and left ventricular outflow obstruction with systolic anterior motion of mitral valve (arrow).](kjae-64-73-g002){#F2}
